SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
Sanofi SNY and partner Regeneron REGN announced that the European Commission has approved Dupixent (dupilumab) for the treatment of…
Common allergy medication’s risks outweigh its usefulness, experts say
AND ON THE SEACOAST, 95 AND 101 ARE DELAY FREE. THIS CAN BE A TOUGH TIME OF YEAR…